Ligand Pharmaceuticals (LGND) Acquisitions (2011 - 2024)
Ligand Pharmaceuticals' (LGND) quarterly Acquisitions came in at -$92.0 million in Q4 2024, down 124.34% quarter-over-quarter from $378.0 million in Q4 2020.
Ligand Pharmaceuticals (LGND) Acquisitions (2011 - 2024) Analysis & Trends
Ligand Pharmaceuticals has disclosed Acquisitions across 7 years of filings, most recently posting -$92.0 million for Q4 2024.
- Acquisitions for Q4 2024 came in at -$92.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$92.0 million (changed N/A YoY), and the FY2023 annual result was $10.4 million, changed N/A from the prior year.
- Acquisitions came in at -$92.0 million for Q4 2024 at Ligand Pharmaceuticals, down from $378.0 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $378.0 million in Q4 2020 to a low of -$92.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 5.47 Bn | 4.69 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -92.00 Mn |
| Dec 31, 2020 | 378.03 Mn |
| Sep 30, 2020 | 11.72 Mn |
| Sep 30, 2019 | 11.84 Mn |
| Dec 31, 2018 | 5.86 Mn |
| Dec 31, 2017 | 26.65 Mn |
| Dec 31, 2016 | -2,000.00 |
| Jun 30, 2016 | 3.00 Mn |
| Mar 31, 2016 | 92.86 Mn |
| Dec 31, 2011 | -32.02 Mn |
| Mar 31, 2011 | 32.02 Mn |